Table 4 Resistance among E. coli from BSI

Any extended spectrum cephalosporin

72/131 (55.0%)

45/74 (60.8%)

39/65 (60%)

6/9 (66.7%)

1

ESBL production

50/111 (45%)

33/61 (54.1%)

28/52 (53.8%)

5/9 (55.6%)

1

Others

22/131 (16.8%)

12/74 (16.2%)

11/65 (16.9%)

1/9 (11.1%)

1

Any carbapenem

1/130 (0.8%)

0/73 (0.0%)

0/64 (0.0%)

0/9 (0.0%)

-

Any aminoglycoside

30/129 (23.3%)

15/73 (20.5%)

14/64 (21.9%)

1/9 (11.1%)

0.675

Any fluoroquinolone

41/129 (31.8%)

26/72 (36.1%)

22/63 (34.9%)

4/9 (44.4%)

0.714

Cotrimoxazole

62/90 (68.9%)

27/38 (71.1%)

24/33 (72.7%)

3/5 (60.0%)

0.615

Fosfomycin

1/52 (1.9%)

1/44 (2.3%)

1/38 (2.6%)

0/6 (0%)

-